RUTHFULLY YOURS

http://verygoodnewsisrael.blogspot.com/ 

ISRAEL’S MEDICAL ACHIEVEMENTS

Fixing the root cause of diabetes. (TY WIN) Hebrew University of Jerusalem Professor Motti Chevion has developed Zygosid-50, the first treatment to restore near-normal cellular sensitivity to insulin, without side effects. Israel’s Concenter BioPharma is preparing to trial Zygosid-50 and give new hope to Type 2 diabetics.

https://www.israel21c.org/finally-a-pill-that-could-fix-the-root-cause-of-diabetes/

The doctor can see you now. (TY Atid-EDI) Israel’s RSIP Vision has developed an Artificial Intelligence-based image analysis solution for tissue diagnosis.  It assists doctors in multiple medical imaging fields: e.g. cardiology, pulmonology, ophthalmology, orthopedics, radiology, robotic surgery, microscopy and more.

https://www.rsipvision.com/   https://www.youtube.com/watch?v=qmCI2hBLrok

A clearer future for children. (TY Atid-EDI) Israel’s NovaSight has developed two products: EyeSwift uses eye-tracking technology to detect multiple vision problems in children (e.g. lazy-eye and squints). CureSight treats lazy-eye using 3D image algorithms and variable focusing, while the child watches entertaining videos.

https://nova-sight.com/about/  https://www.youtube.com/watch?v=i5HnxVW_JUo

Discovery prevents preemie lung collapse. Scientists at Israel’s Technion Institute built a 3D model of the lungs of a premature baby. They discovered that in standard respirators for babies an air jet could cause damage to the infant. They have now recommended reconfiguring the air flow, potentially saving many young lives.

https://unitedwithisrael.org/preemies-breathe-easier-with-israeli-breakthrough/

https://www.technion.ac.il/en/2020/01/innovation-for-infant-assisted-ventilation/

Micro robot is revealed. Israel’s Microbot Medical previously demonstrated a prototype of its self-cleaning shunt for cleaning blockages in the brain (see here). At the J.P. Morgan Healthcare Conference, Microbot demonstrated LIBERTY – the world’s first fully disposable robotic system for endovascular procedures.

https://microbotmedical.gcs-web.com/news-releases/news-release-details/microbot-medical-unveil-worlds-first-fully-disposable-robotic   https://www.fiercebiotech.com/medtech/jpm-microbot-medical-unveils-disposable-device-for-remote-catheter-procedures

https://www.jpost.com/Opinion/Gantzs-stammering-stance-and-Netanyahus-mudslinging-615191

Of all the mud slung at Prime Minister Benjamin (Bibi) Netanyahu, this week’s phony scandal surrounding comments he made about his key rival in the upcoming Knesset elections deserves a prize for the slimiest.

The orchestrated outrage in question followed the launch of the Likud Party campaign on Tuesday evening in Jerusalem. During the flashy event – which resembled a rock concert replete with adoring fans – Netanyahu ridiculed Blue and White chairman Benny Gantz for being indecisive and ill-fit to lead the country.The way he did this was to show a video clip of Gantz fumfering in response to questions about policy, and then to imitate the Blue and White leader’s faltering.

Making fun of the fact that Gantz’s entire platform is based on an “anybody but Bibi” mantra, Netanyahu said, “It used to be ‘either us or them.’ Today, it’s ‘either us or eh, eh, eh.’ Now the question is, ‘What would they be doing? What would they be doing if they were [heading] the government?”

Nothing unusual there. Kicking off a political campaign by pointing out the flaws of one’s opponent is par for the course. Nobody knows this better than Gantz, whose fledgling political career has consisted solely of attacks on Netanyahu.

https://www.gatestoneinstitute.org/15470/arab-singer-israel-jordan

The Arab citizens [of Israel]… are seeking integration into Israel, and not separation.

The committee, like other anti-Israel groups around the world, particularly the Boycott, Divestment and Sanctions (BDS) movement, are opposed to visits to Israel because they want to keep the world in the dark. The whole idea of boycotting Israel is designed to prevent the world from learning about the good things that Israel stands for and actually provides.

These groups are afraid that Maraka will go back to Jordan and report that he was welcomed in Israel by both Arabs and Jews, and that he was harassed by no one.

That is not a pretty picture for Israel-haters. These groups want the world to think that Arab citizens are being oppressed by Israel and have no rights. That, of course, is completely false. As a minority, Arabs in Israel enjoy more rights than in many of their own Arab and Muslim countries.

Here is a new one for the books: An Arab singer stands up to perform in front of an Arab audience, and the anti-Israel brigade goes berserk.

What has so inflamed the Israel haters this time?

https://www.jns.org/opinion/holocaust-remembrance-palestinian-irrelevance/

Bemoaning all the apparent attention on the Jews prior to the Fifth World Holocaust Forum in Jerusalem, a columnist for the official Palestinian Authority daily newspaper “Al-Hayat Al-Jadida” proposed murder as a solution to stop the proceedings.

(JNS) As the nearly 50 heads of state from around the globe began preparing for their arrival in Israel this week to attend the Fifth World Holocaust Forum—on the occasion of the 75th anniversary of the 1945 liberation of the Auschwitz-Birkenau concentration and death camp from the Nazis—the powers-that-be in the Palestinian Authority have been busy trying to figure out how best to channel their anger and envy.

Unfortunately for P.A. head Mahmoud Abbas and his disgruntled Fatah henchmen, however, nobody really cares—least of all U.S. Vice President Mike Pence, who will be representing the White House at the somber Jan. 23 “Remembering the Holocaust: Fighting Anti-Semitism” event hosted by Israeli President Reuven Rivlin and Yad Vashem, the World Holocaust Remembrance Center in Jerusalem.

The significance of the major happening is magnified by the recent spike in worldwide anti-Semitism, even in America, where the rearing of its ugly head in heavily Orthodox neighborhoods has been almost as shocking as its explosion on university campuses.

To the dismay of the aging Abbas, who alternates between denying the Holocaust—as he did in his Ph.D. thesis—and accusing the Jewish state of committing Nazi-like crimes against the Palestinians, very few members of the diverse group of dignitaries gathering in the Israeli capital that he does not recognize will be taking a break in their whirlwind visit to pay their respects, or even lip service, to him.

Bemoaning the above, a regular columnist for the official P.A. daily newspaper, Al-Hayat Al-Jadida, proposed murder as a solution.

https://bit.ly/30JE01o

1. 2000 to 2019:

*Population – from 6.2 million to 9.1 million (47% growth);
*Gross Domestic Product (GDP) – from $132BN to $404BN (206% growth);
*GDP per capita – from $21,000 to $44,000 (110% growth);
*Export – from $47BN to $117BN (149% growth);
*Women in the workforce – from 48% to 60% (25% growth);
*University/college students – from 70,000 to 316,000 (351% growth);
*Incoming tourists – from 2.31 million to 4.87 million (108% growth);
*Water desalination – from 2% to 26% (1,300% growth);
*Foreign exchange reserves – from $24BN to $119BN (396% growth);
*Government debt per GDP – from 77% to 58.5% (24.7% reduction);
*US “aid” per GDP – from 2.3% to 1% (57% reduction);
*Defense budget per GDP – from 9% to 5% (44% reduction);
*Tax burden – from 43% to 32% (26% reduction);
*Number of vehicles per 1,000 people – from 277 to 396 (43% growth);
*Emigrants per 100,000 people – from 340 to 160 (51% reduction).

Source: Dr. Adam Reuter, the Chairman and Founder of “Financial Immunities,” Israel’s largest financial-risk management firm, and the co-author of Israel – Island of Success.

http://verygoodnewsisrael.blogspot.com/

ISRAEL’S MEDICAL ACHIEVEMENTS

US approves freezing of tumors. The US FDA has granted approval for Israel’s IceCure Medical to use its tumor-freezing technology to destroy cancerous and benign tumors of the kidney, liver, ear, nose, and throat. It already has FDA approval for benign breast tumors and European approval to treat malignant breast tumors.

https://www.calcalistech.com/ctech/articles/0,7340,L-3777254,00.html

UK hospital introduces Israeli remote diagnostic device. (TY OurCrowd) As reported previously (see here), Israel’s TytoCare device allows for doctors to examine patients from remote locations. Bradford Teaching Hospitals NHS Foundation Trust is to be the first provider in the UK to partner with TytoCare.

https://pharmaphorum.com/news/uk-hospital-introduces-tytocare-remote-medical-exam-device/

https://www.tytocare.com/

Israeli treatment in Mass trials. (TY Atid-EDI) Pridopidine, from Israeli biotech Prilenia, has been chosen by the Healey Center at Massachusetts General hospital for the first-ever platform (multiple treatments) trial for amyotrophic lateral sclerosis (ALS). Prilenia is trialing Pridopidine for several neurodegenerative disorders.

https://www.prilenia.com/18-september-2019-pr

https://www.massgeneral.org/neurology/als/research/platform-trial

Two potential IBD therapies. (TY Atid-EDI) As reported previously (see here) Israel’s Biomica is using the human microbiome (stomach bacteria) to fight cancer, IBD, acne etc. Bionica is starting pre-clinical studies for BMC321 & BMC322, two developed microbial consortia aimed to treat Inflammatory Bowel Disease (IBD).

https://www.biomicamed.com/press-releases/biomica-announces-advancement-to-pre-clinical-studies-in-it inflammatory-bowel-disease-program/

Spotting problems that doctors may have missed. Israel-based medical device startup IMedis AI develops technology that analyzes medical images and documents to reveal discrepancies and unreported findings. The technology can assist in the early detection of cancer, heart diseases, and vascular diseases.

https://www.calcalistech.com/ctech/articles/0,7340,L-3777150,00.html   https://www.imedis.ai/

Women at risk of diabetes during pregnancy. Scientists at Israel’s Weizmann Institute have developed an algorithm that can predict which women have a high risk of gestational diabetes. Records of 600,000 Israeli pregnancies were examined. Those found to be at risk could avoid diabetes with exercise and diet.

https://wis-wander.weizmann.ac.il/life-sciences/new-algorithm-predicts-gestational-diabetes

https://www.nature.com/articles/s41591-019-0724-8

An all-in-one genetic test. Israel’s Variantyx has developed the first comprehensive, all-in-one diagnosis test for rare inherited disorders. It eliminates the need to order multiple tests, saving time, money and (potentially) lives. There are more than 7,000 rare diseases, affecting 30 million in the US and over 350 million globally.

https://www.jpost.com/Opinion/Hillels-Tech-Corner-Genome-sequencing-gets-deeper-613721

https://www.variantyx.com/solutions/diagnostic-testing/

Helping patients breathe. (TY Atid-EDI) Israel’s Biovo Technologies manufactures the Airway Medix line of disposable respiratory devices, used for mechanically ventilated (usually unconscious) intubated ICU patients.

https://www.biovo-tech.com/  http://www.airwaymedix.com/en,2,products

Don’t over-vaccinate your pet. (TY Atid-EDI) Israel’s Biogal-Galed Labs (reported here previously) has launched CombCam, an automated reading device that helps veterinarians interpret antibody and vaccine tests on animals. Biogal’s various veterinary diagnostic products are now available in over 35 countries.

https://www.prnewswire.com/il/news-releases/biogal-galed-labs-launches-combcam-an-automated-reading-device-for-biogals-vaccicheck-and-immunocomb-kits-300920779.html

https://www.youtube.com/watch?v=2Nur-i347hU  https://www.biogal.com/products/combcam/

From cancer to shrimps. This article focuses on Dr Avi Schroeder of Israel’s Technion Institute. His company PEEP Therapeutics is developing a cancer treatment based on Elephant protein gene P53 (see here).  He is also working on personalized chemotherapy and a cure for a deadly shrimp virus. He is a manager in four startups.

https://www.calcalistech.com/ctech/articles/0,7340,L-3777084,00.html

Israeli medical startups in San Francisco. 16 of OurCrowd’s Israeli medical portfolio companies attended the 38th annual J.P. Morgan Healthcare Conference in San Francisco (Jan 13-15). Their innovative solutions include cancer treatments, blood testing, wound care, care for older adults, diabetes management and more.

https://cdn2.hubspot.net/hubfs/353882/OurCrowd%20@%20JPM%20Health.pdf

Israeli startups to help UK healthcare. Ten Israeli heath tech startups have been invited by UK Government’s Israel Tech Hub to help UK healthcare organizations build more modern and effective healthcare services. They will meet AstraZeneca, NHSX, Care UK, Walgreens Boots Alliance and Amazon Web Services in London.

https://www.timesofisrael.com/israeli-health-tech-startups-to-head-to-uk-to-showcase-wares/

ttps://www.spectator.com.au/2020/01/keep-an-eye-out-for-israel-derangement-syndrome/

I am not a psychiatrist, but I’ve observed a kind of psychosis in far-left activists of the West who claim to be progressives championing the Palestinian cause: Israel Derangement Syndrome, or IDS.

Sufferers of this insidious illness don’t rationally advocate for Palestinians and criticise Israeli policies, in the same way they’d criticise other states. They are doctrinaire cultists possessed of an unadulterated, unhinged hatred for Israel, which they see as a uniquely evil state that must be eradicated. Until then, it will be their all-consuming, defining cause; never mind the Uyghurs, Kurds or Iranian women. In indulging in the delusion that the end (of Israel) goal will eventually occur, they are complicit in perpetuating the conflict and emboldening the despotic regimes that act against the interests of the very people they purport to champion, the Palestinians.

Corbynism is the most recent prominent example of IDS. While we will no longer be bombarded with its leader’s sneering visage, the animosity towards Israel that its dogmatism exemplifies, replete with conspiracism and terrorist sympathising, is unlikely to fade. And it is rising across the Atlantic